Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Diversa Corporation (DVSA) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (51)	10/24/2001 9:41:33 AM
From: nigel bates	Read Replies (1) \| Respond to of 144

Diversa Expands Biodiversity Network to Include Environments in Ghana and Kenya SAN DIEGO, Oct. 23 /PRNewswire/ -- Diversa Corporation (Nasdaq: DVSA - news) today announced the signing of biodiversity access and research collaboration agreements in Ghana and Kenya, further extending Diversa's global access to biodiversity through its collection and collaboration network. These agreements with The Department of Biochemistry at the University of Ghana and The Kenya Wildlife Service, in partnership with The International Centre for Insect Physiology and Ecology (ICIPE) in Kenya, give Diversa the rights to discover genes and commercialize products from small environmental samples. In exchange, Diversa will provide scientific training, annual research support, and royalties on Diversa's revenues from products developed under the agreements. The high levels of biodiversity in numerous environments in Ghana and Kenya make them valuable additions to Diversa's collection and collaboration network. Environments of particular interest to Diversa are the alkaline lakes of the Great Rift Valley, such as Lakes Turkana, Bogoria, and Nakuru. In addition, Ghana's forest zone and Kenya's southeastern coastal area have been included among 25 global ``hotspots'' that contain high levels of biodiversity and many endemic species. ``By accessing biodiversity globally, Diversa is able to combine discovery of novel genes with laboratory evolution technologies to develop products with characteristics superior to those of products identified using traditional culturing methods or through accessing public databases,'' stated Dr. Jay M. Short, President and Chief Executive Officer of Diversa. ``Diversa is targeting high-value product opportunities such as orally active drugs, including new antibiotics and antifungals, as well as novel biocatalysts, all of which can be discovered and developed from small environmental samples using our patented technologies.'' Recognizing that the value of biodiversity should be shared with the countries of origin, Diversa has established itself as the leader in authorized access to genetic diversity around the world. Diversa's relationships have been founded on the fundamental principles of the Convention on Biological Diversity, including: conservation of biological diversity; the sustainable use of its components; and the fair and equitable sharing of the benefits derived from the utilization of genetic resources. To date, Diversa has entered into legal agreements to obtain samples from Alaska, Antarctica, Bermuda, Costa Rica, Ghana, Iceland, Indonesia, Kenya, Mexico, the Meadowlands Superfund site, Russia, South Africa, and Yellowstone National Park...